Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma
Stopped early · Phase 2
Conditions studied: Malignant Mesothelioma
In brief
Current therapies for advanced Mesothelioma provide limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of advanced Mesothelioma. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with advanced Mesothelioma.
Key facts
- Study ID
- NCT00003508
- Run by
- Burzynski Research Institute
- People needed
- 8
- Starts
- 1996-03-08
- Expected to finish
- 2005-04-26
- Last updated by the study team
- 2021-04-27
Who can join
Age: 1 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Burzynski Clinic — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.